5'-AMP-Activated Protein Kinase Catalytic Subunit Alpha-2 (PRKAA2) Antibody

Product Graph
312€ (60 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
5'-AMP-Activated Protein Kinase Catalytic Subunit Alpha-2 (PRKAA2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx006920
tested applications
WB, IF/ICC

Description

PRKAA2 Antibody is a Rabbit Polyclonal Antibody against PRKAA2.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
5'-AMP-Activated Protein Kinase Catalytic Subunit Alpha-2 (PRKAA2)
Host
Rabbit
Reactivity
Human, Rat
Recommended Dilution
WB: 1/500 - 1/1000, IF/ICC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified by affinity chromatography.
Size 1
60 µl
Size 2
120 µl
Size 3
200 µl
Form
Liquid
Tested Applications
WB, IF/ICC
Buffer
PBS, pH 7.3, containing 0.05% Proclin-300.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P54646
Gene ID
5563
NCBI Accession
NP_006243.2
Background
Antibody anti-PRKAA2
Status
RUO
Note
Concentration: 1 mg/ml -

Descripción

Related Products

EH1140

Human PRKAA2 (5'-AMP-activated protein kinase catalytic subunit alpha-2) ELISA Kit

Ver Producto
FNab00376

PRKAA2 antibody

PRKAA2(protein kinase, AMP-activated, alpha 2 catalytic subunit), also named as AMPKA2, AMPK, PRKAA, AMPK2, belonogs to the CAMK Ser/Thr protein kinase family and SNF1 subfamily. PRKAA2 is an αβγ heterotrimer that is activated by low cellular energy status, such as decreases in both the ATP/AMP ratio and the phosphocreatine content and it is a glycogen synthase kinase, phosphorylating Ser7 at the NH2 terminus, which decreases glycogen synthase activity(PMID:14532170). The protein can be ubiquitinated(PMID:21224036).

Ver Producto
P0340

Recombinant Human PRKAA2

Ver Producto